P1.14-17 Identification of Molecular Subtypes of Thymic Epithelial Tumors and Novel Treatments Using a Computational Biological Model

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.919
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.14-21 Circulating Biomarkers in Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Novel Biologic Therapies for Thymic Epithelial Tumors

Frontiers in Oncology
Cancer ResearchOncology
2014English

P1.14-28 Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.14-16 DNA Methylation of GNG4、GHSR、HOXD9 and SALL3 Genes Predict Malignant Behavior of Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.14-11 the Expression Pattern of Programmed Death-Ligand 1 According to the Pathological Type of Malignant Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

ES08.03 Mesothelioma, Thymic Epithelial Tumors and Others

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Immune Checkpoints in Thymic Epithelial Tumors: Challenges and Opportunities

Immuno-Oncology Technology
2019English

Detection of Human Polyomavirus 7 in Human Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy